PAY NO MORE THAN $25
Most patients with primary insurance pay the first $25, Intendis covers the remaining cost up to $125!

Please fill out the form below and hit "SUBMIT". Then print out the Instant Savings Voucher and mail to the address listed on the voucher.



* All fields are required.


First name:
Last name:
E-mail address:
Address:
City:
State:
Postal/ZIP code:

Yes, I would like to receive materials about atopic dermatitis (eczema), dermatology related health topics and special tips!

Terms and Conditions

Intendis values your privacy and the confidentiality of your personal information. By submitting the information below, I give Intendis (and those agents working on its behalf) permission to: 1) Provide me with materials about atopic dermatitis (eczema). 2) Contact me about dermatology-related health topics. 3) Use my information to help develop new products, services, and programs relating to dermatology. I can revoke this authorization at any time by choosing the unsubscribe option within every email, or mailing /faxing a written request to Intendis, 36 Columbia Road , PO Box 1941, Morristown, NJ 07962-1941, Fax: 973-966-3378. This authorization expires three (3) years after the last communication between me and Intendis. Intendis will use your information only to provide you with materials and information relating to atopic dermatitis.

By clicking on "submit" you agree with the above terms and conditions.

Click submit to complete the sign up process


INDICATION & USAGE


Desonate Gel is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.

IMPORTANT SAFETY INFORMATION


As with other corticosteroids, therapy should be discontinued when control is achieved. Unless directed by a physician, the treated skin area should not be bandaged so as to be occlusive. Systemic absorption of topical corticosteroids, including Desonate Gel, has produced HPA axis suppression, for which pediatric patients are more susceptible.

In clinical trials, the most frequent adverse events included headache (2%), application site burning (1%), rash (1%), and application site pruritus (<1%). The safety of Desonate Gel has not been established beyond 4 weeks of use.

Desonate Gel is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Desonate Gel is for topical use only. Desonate Gel is not for ophthalmic, oral, or intravaginal use.

Desonate Gel is not indicated for the treatment of diaper dermatitis.

Please see full prescribing information for Desonate.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch or call 1-888-INFO-FDA.

Intendis reserves the right to terminate or modify this Instant Savings program at its sole discretion and without notice. Desonate® is a registered trademark of Intendis, Inc.